Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Frontotemporal Dementia w/ Parkinsonism (FTDP) - MAPT Gene Center for Genetics at Saint Francis Saint Francis Hospital United States | 1 | 1 |
|
Frontotemporal Dementia (FTDP) - MAPT Gene, Exon 10 Only Center for Genetics at Saint Francis Saint Francis Hospital United States | 1 | 1 |
|
MAPT Gene Dementia, frontotemporal NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 94 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 51 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Microdeletion / Microduplication Syndromes Molecular Genetics and Cytogenetics, Clinical Laboratory Service RED DE SALUD UC CHRISTUS Chile | 28 | 39 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 184 | 162 |
|
Invitae Frontotemporal Dementia with C9orf72 Panel Invitae United States | 30 | 14 |
|
MAPT - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 78 | 76 |
|
Amyotrophic Lateral Sclerosis (ALS) / Dementia Panel Centogene AG - the Rare Disease Company Germany | 64 | 66 |
|
Genomic Unity® Dementia Analysis Variantyx, Inc. United States | 6 | 32 |
|
Invitae United States | 72 | 33 |
|
PreventionGenetics, part of Exact Sciences United States | 27 | 19 |
|
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel PreventionGenetics, part of Exact Sciences United States | 48 | 39 |
|
Pick disease, 172700, Autosomal dominant, Isolated cases (Frontotemporal dementia) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.